Joseph P. Slattery
Independent DirectorMr. Joseph P. Slattery, also known as Joe, CPA, has been a Director of ImageneBio, Inc. since November 1, 2025. He has been an Independent Director of Morphic Holding, Inc. since May 2019. He serves as Independent Director at Omega Alpha Spac since January 2021. Mr. Slattery served as Chief Financial Officer and Executive Vice President of TransEnterix, Inc. (Asensus Surgical, Inc) from October 2, 2013 to December 31, 2019. Mr. Slattery served as the Chief Financial Officer, Chief Accounting Officer and Executive Vice President at Baxano Surgical, Inc. from April 19, 2010 to September 27, 2013. He served as Chief Financial Officer of QIAGEN Gaithersburg, Inc. from October 1, 2006 to July 2007 and served as its Principal Accounting Officer. He served as Senior Vice President of Finance and Information Systems of QIAGEN Gaithersburg, Inc., from September 2002 to July 2007 and was responsible for its global finance and information technology operations. Mr. Slattery served as Controller of QIAGEN Gaithersburg, Inc., from February 1996 to July 2000 and Vice President of Finance from July 1999 to September 2002 and served as a Member of its senior management for 10 years. Prior to joining in QIAGEN Gaithersburg in 1996, he served as an Audit Manager of KPMG and Staff Auditor of Ernst & Young. He was a Director of Exosome Diagnostics, Inc., since July 8, 2013. He serves as an Independent Director at CVRx, Inc. since October 2008 and as its Independent Lead Director from February 2024. He is Director of Morphic Therapeutic, Inc. He serves as an Independent Director of Replimune Group, Inc. since October 2017 and had been its Lead Independent Director since March 13, 2019 until March 31, 2020. He served as a Director of Micromet, Inc. from November 16, 2007 to March 7, 2012 and Baxano Surgical, Inc., from November 2007 to April 19, 2010. From February 1996 to August 2007, Mr. Slattery served in various roles of increasing responsibility at Digene Corporation, a molecular diagnostics company that was acquired by Qiagen, N.V. in August 2007, including from October 2006 through August 2007 as Chief Financial Officer and Senior Vice President of Finance and Information Systems. Mr. Slattery holds Bachelor of science in Accounting from Bentley College in 1987 and is a Certified Public Accountant.
Positions
- Company NameReplimune Group, Inc.Stock CodeREPLPositionIndependent DirectorColleagues
- SPSushil PatelCEO & Director
- PAPhilip Astley-SparkeExecutive Chairman
- ELEmily Luisa HillChief Financial Officer
- KXKonstantinos XynosChief Medical Officer
- NANina AragamChief Operations Officer
- DWDieter WeinandLead Independent Director
- JPJoseph P. SlatteryIndependent Director
- CJChristy J. OligerIndependent Director
- Company NameCVRx, Inc.Stock CodeCVRXPositionIndependent Lead DirectorColleagues
- KHKevin HykesPresident, CEO & Director
- PBPhilip B. AdamsonChief Medical Officer
- JLJohn LandryChief Financial Officer
- BBBrent BinkowskiChief Operating Officer
- MKMatt KleinVice President, Legal & Compliance Officer
- MKMudit K. JainIndependent Director
- KGKirk G. NielsenIndependent Director
- MCMitchell C. HillIndependent Director
- JPJoseph P. SlatteryIndependent Lead Director
- Company NameImageneBio, Inc.Stock CodeIMAPositionDirectorColleagues
- KYKristin YaremaCEO & Director
- JJJonathan Jian WangChairman
- YGYanina Grant-HuertaCFO, Principal Financial Officer & Principal Accounting Officer
- KPKurinji PandiyanChief Strategy & Operations Officer
- RSRenuka SivendranChief Technical Officer
- MRMatt RobbinsGeneral Counsel
- DBDavid BonitaLead Independent Director
- OSOtello StampacchiaIndependent Director
